Engineering of Therapeutic and Detoxifying Enzymes

Michailidou, Freideriki

doi:10.1002/ange.202308814

Cited by 2 publications

(1 citation statement)

References 102 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Protein delivery systems have various applications in biological research and therapeutics. They can be applied to enhance the therapeutic enzymes’ effectiveness and selectivity, enabling the treatment of human illnesses and detoxification . The application of protein delivery systems in targeted drug delivery enables the encapsulation and distribution of medications to certain body locations, increasing drug bioavailability and lowering systemic toxicity.…”

Section: Introductionmentioning

confidence: 99%

Metal–Organic Framework Induced Stabilization of Proteins in Polymeric Nanoparticles

Khan,

Armstrong,

Lenertz

et al. 2024

ACS Appl. Mater. Interfaces

View full text Add to dashboard Cite

Developing protein confinement platforms is an attractive research area that not only promotes protein delivery but also can result in artificial environment mimicking of the cellular one, impacting both the controlled release of proteins and the fundamental protein biophysics. Polymeric nanoparticles (PNPs) are attractive platforms to confine proteins due to their superior biocompatibility, low cytotoxicity, and controllable release under external stimuli. However, loading proteins into PNPs can be challenging due to the potential protein structural perturbation upon contacting the interior of PNPs. In this work, we developed a novel approach to encapsulate proteins in PNPs with the assistance of the zeolitic imidazolate framework (ZIF). Here, ZIF offers an additional protection layer to the target protein by forming the protein@ZIF composite via aqueous-phase cocrystallization. We demonstrated our platform using a model protein, lysozyme, and a widely studied PNP composed of poly(ethylene glycol)poly(lactic-co-glycolic acid) (PEG−PLGA). A comprehensive study via standard loading and release tests as well as various spectroscopic techniques was carried out on lysozyme loaded onto PEG−PLGA with and without ZIF protection. As compared with the direct protein encapsulation, an additional layer with ZIF prior to loading offered enhanced loading capacity, reduced leaching, especially in the initial stage, led to slower release kinetics, and reduced secondary structural perturbation. Meanwhile, the function, cytotoxicity, and cellular uptake of proteins encapsulated within the ZIF-bound systems are decent. Our results demonstrated the use of ZIF in assisting in protein encapsulation in PNPs and established the basis for developing more sophisticated protein encapsulation platforms using a combination of materials of diverse molecular architectures and disciplines. As such, we anticipate that the protein-encapsulated ZIF systems will serve as future polymer protein confinement and delivery platforms for both fundamental biophysics and biochemistry research and biomedical applications where protein delivery is needed to support therapeutics and/or nutrients.

show abstract

Section: Introductionmentioning

confidence: 99%